Inventor · disambiguated record
Kenneth J. Barr
Also filed as: BARR KENNETH · BARR KENNETH J · BARR KENNETH JAY
47 granted patents·11 pending applications·813 citations·filing 1982–2020
99Inventor score
Top patents by PatentIndex Score
58 records- 0198US8084047B2Compositions and methods for treatment of eye disordersSHEN WANG·Filed 2009·Granted Dec 27, 2011·58 cites·5 claims
- 0297US10124000B2Modulators of cellular adhesionSARCODE BIOSCIENCE INC·Filed 2015·Granted Nov 13, 2018·20 cites·14 claims
- 0397US9216174B2Modulators of cellular adhesionSARCODE BIOSCIENCE INC·Filed 2013·Granted Dec 22, 2015·39 cites·12 claims
- 0497US7928122B2Modulators of cellular adhesionSARCODE CORP·Filed 2009·Granted Apr 19, 2011·43 cites·10 claims
- 0597US7314938B2Modulators of cellular adhesionSUNESIS PHARMACEUTICALS INC·Filed 2004·Granted Jan 1, 2008·86 cites·62 claims
- 0696US7790743B2Modulators of cellular adhesionSARCODE CORP·Filed 2007·Granted Sep 7, 2010·32 cites·69 claims
- 0795US7745460B2Modulators of cellular adhesionSARCODE CORP·Filed 2007·Granted Jun 29, 2010·25 cites·37 claims
- 0895US6521658B1Cell proliferation inhibitorsABBOTT LAB·Filed 2000·Granted Feb 18, 2003·59 cites·11 claims
- 0994US9663522B23-aminocycloalkyl compounds as RORgammaT inhibitors and uses thereofMERCK SHARP & DOHME·Filed 2013·Granted May 30, 2017·15 cites·22 claims
- 1094US7989626B2Modulators of cellular adhesionSAR CODE CORP·Filed 2011·Granted Aug 2, 2011·30 cites·4 claims
- 1193US9045457B2Compositions and methods for treatmentSARCODE BIOSCIENCE INC·Filed 2013·Granted Jun 2, 2015·9 cites·20 claims
- 1293US7767687B2Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as RAF kinase inhibitorsBIOGEN IDEC INC·Filed 2005·Granted Aug 3, 2010·28 cites·60 claims
- 1392US10221146B2Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2017·Granted Mar 5, 2019·6 cites·18 claims
- 1492US9809561B2Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2014·Granted Nov 7, 2017·8 cites·16 claims
- 1592US9663502B22-Acylamidomethyl and sulfonylamidomethyl benzoxazine carbamates for inhibition of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2014·Granted May 30, 2017·12 cites·26 claims
- 1692US9657033B2Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORγ activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2013·Granted May 23, 2017·20 cites·44 claims
- 1792US9266827B2Bicyclic sulfone compounds for inhibition of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2013·Granted Feb 23, 2016·23 cites·52 claims
- 1891US9783511B2Carbamate benzoxazine propionic acids and acid derivatives for modulation of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2014·Granted Oct 10, 2017·9 cites·21 claims
- 1991US9603838B2RORgammaT inhibitorsMERCK SHARP & DOHME·Filed 2015·Granted Mar 28, 2017·16 cites·20 claims
- 2090US9556168B2N-alkylated indole and indazole compounds as RORgammaT inhibitors and uses thereofMERCK SHARP & DOHME·Filed 2013·Granted Jan 31, 2017·16 cites·23 claims
- 2189US9487490B23-cyclohexenyl and cyclohexyl substituted indole and indazole compounds as RORgammaT inhibitors and uses thereofMERCK SHARP & DOHME·Filed 2013·Granted Nov 8, 2016·15 cites·24 claims
- 2289US9095583B2RORgammaT inhibitorsKARSTENS WILLEM FREDERIK JOHAN·Filed 2012·Granted Aug 4, 2015·25 cites·19 claims
- 2387US10377768B2Tetrahydronaphthyridine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2017·Granted Aug 13, 2019·6 cites·28 claims
- 2486US9745265B24-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereofMERCK SHARP & DOHME·Filed 2013·Granted Aug 29, 2017·9 cites·29 claims
- 2586US8771715B2Compositions and methods for treatmentOSLOB JOHAN·Filed 2011·Granted Jul 8, 2014·4 cites·19 claims
- 2684US8071617B2Modulators of cellular adhesionSHEN WANG·Filed 2011·Granted Dec 6, 2011·4 cites·6 claims
- 2784US6310095B1Inhibitors of protein isoprenyl transferasesUNIV PITTSBURGH·Filed 1998·Granted Oct 30, 2001·39 cites·14 claims
- 2883US9884043B2RORgammaT inhibitorsMERCK SHARP & DOHME·Filed 2017·Granted Feb 6, 2018·4 cites·19 claims
- 2983US9248126B2Modulators of cellular adhesionSARCODE BIOSCIENCE INC·Filed 2013·Granted Feb 2, 2016·3 cites·9 claims
- 3082US8758776B2Compositions and methods for treatmentOSLOB JOHAN·Filed 2011·Granted Jun 24, 2014·2 cites·19 claims
- 3181US9051297B2Compositions and methods for treatmentSARCODE BIOSCIENCE INC·Filed 2014·Granted Jun 9, 2015·1 cites·4 claims
- 3281US6221865B1Inhibitors of protein isoprenyl transferasesUNIV PITTSBURGH·Filed 1998·Granted Apr 24, 2001·30 cites·15 claims
- 3379US6784205B2Compounds that modulate the activity of PTP-1B and TC-PTPSUNESIS PHARMACEUTICALS INC·Filed 2003·Granted Aug 31, 2004·12 cites·24 claims
- 3479US6204293B1Inhibitors of protein isoprenyl transferasesUNIV PITTSBURGH·Filed 1998·Granted Mar 20, 2001·26 cites·15 claims
- 3578US10221142B2Substituted pyrazole compounds as RORgammaT inhibitors and uses thereofMERCK SHARP & DOHME·Filed 2016·Granted Mar 5, 2019·3 cites·29 claims
- 3678US10196354B24-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereofMERCK SHARP & DOHME·Filed 2017·Granted Feb 5, 2019·2 cites·29 claims
- 3777US6376524B1Triphenyl compounds as interleukin-4 antagonistsSUNESIS PHARMACEUTICALS INC·Filed 2000·Granted Apr 23, 2002·14 cites·15 claims
- 3875US6693123B2Inhibitors of protein isoprenyl transferasesUNIV PITTSBURGH·Filed 2001·Granted Feb 17, 2004·7 cites·7 claims
- 3975US2021145824A1Modulators of cellular adhesionNOVARTIS PHARMACEUTICALS CORP·Filed 2020·Application pending·0 cites
- 4073US9045458B2Compositions and methods for treatmentSARCODE BIOSCIENCE INC·Filed 2014·Granted Jun 2, 2015·0 cites·4 claims
- 4171US6228868B1Oxazoline antiproliferative agentsABBOTT LAB·Filed 1999·Granted May 8, 2001·32 cites·7 claims
- 4271US2019134022A1Modulators of cellular adhesionSARCODE BIOSCIENCE INC·Filed 2018·Application pending·0 cites
- 4370US2014099387A1Compositions and methods for treatmentSARCODE BIOSCIENCE INC·Filed 2013·Application pending·0 cites
- 4470US2014073666A1Compositions and methods for treatmentSARCODE BIOSCIENCE INC·Filed 2013·Application pending·0 cites
- 4565US10745364B2Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of diseaseMERCK SHARP & DOHME·Filed 2019·Granted Aug 18, 2020·0 cites·18 claims
- 4662US6924304B2Cell proliferation inhibitorsABBOTT LAB·Filed 2002·Granted Aug 2, 2005·2 cites·8 claims
- 4762US2012035154A1Modulators of Cellular AdhesionSHEN WANG·Filed 2011·Application pending·0 cites
- 4854US2012041019A1Protease inhibitorsMUTZ MITCHELL W·Filed 2009·Application pending·0 cites
- 4952US2005187246A1Cell proliferation inhibitorsFiled 2005·Application pending·0 cites
- 5051US2012022040A1AntimicrobialsMUTZ MITCHELL W·Filed 2009·Application pending·0 cites
Showing the top 50 of 58 patent records by PatentIndex Score.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →